<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Intent To Grant Start-Up Exclusive Patent License: Real-Time PCR Point Mutation Assays for Detecting HIV-1 Resistance to Antiviral Drugs</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Intent To Grant Start-Up Exclusive Patent License: Real-Time PCR Point Mutation Assays for Detecting HIV-1 Resistance to Antiviral Drugs</h1>
    <p class="timestamp">Published: 2015-09-29 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the Public Health Service, Department of Health and Human Services, is contemplating the grant of an exclusive license to Research Think Tank Molecular Diagnostics, Inc. (RTTMDx) having a principal place of business in Georgia, U.S.A., to practice the inventions embodied in U.S. Provisional Patent Application No. 60/ 577,696, filed June 07, 2004, entitled "Real-Time PCR Point Mutation Assays for Detecting the 103N and 184...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2015-24674</p>
    <p><strong>Publication Date:</strong> 2015-09-29</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2015/09/29/2015-24674/prospective-intent-to-grant-start-up-exclusive-patent-license-real-time-pcr-point-mutation-assays">https://www.federalregister.gov/documents/2015/09/29/2015-24674/prospective-intent-to-grant-start-up-exclusive-patent-license-real-time-pcr-point-mutation-assays</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2015-24674</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
